Initial Exploration of the In Vitro Activation of GLP-1 and GIP Receptors and Pancreatic Islet Cell Protection by Salmon-Derived Bioactive Peptides
Marine Drugs · 30.10.2024 · 22 (11) · 490
DOI: 10.3390/md22110490 ↗Kurz gefasst
Fachartikel in der Zeitschrift Marine Drugs, online erschienen am 30.10.2024. Verfasst von Crawford Currie und 2 weiteren Autor:innen. Beteiligte Einrichtung: HBC Immunology Inc., Menlo Park, CA 2043, USA. Hauptthemen laut MEDLINE: Glucagon-Like Peptide-1 Receptor, Islets of Langerhans, Receptors, Gastrointestinal Hormone, Glucagon-Like Peptide-1 Receptor Agonists. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: HBC Immunology.
Abstract (Originalsprache)
This study examines the in vitro effects of a soluble protein hydrolysate (SPH) derived from Atlantic salmon (Salmo salar) on incretin receptor activity and pancreatic islet cell protection to explore the mechanisms underlying SPH’s observed benefits on weight loss and metabolic health in overweight individuals. SPH demonstrated a dose-dependent enhancement of glucagon-like peptide-1 (GLP-1) and gastric inhibitory polypeptide (GIP) receptor activity, with significant increases of 2.4-fold (p < 0.05) and 2.6-fold (p < 0.01) at 10 mg/mL, respectively, compared to the control. Pancreatic islet cell assays showed a substantial proliferation effect, with up to a 57% increase at 50 µL/well, indicating potential protective properties against inflammation-induced cell loss. Notably, the smallest SPH peptide fraction (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- HBC Immunology Inc., Menlo Park, CA 2043, USA.
- Hofseth BioCare, 6003 Ålesund, Norway.
ORCID-Profile: Bomi Framroze
Förderung
- HBC Immunology
Zitieren
APA
Currie, C., Bjerknes, C., & Framroze, B. (2024). Initial Exploration of the In Vitro Activation of GLP-1 and GIP Receptors and Pancreatic Islet Cell Protection by Salmon-Derived Bioactive Peptides. Marine Drugs, 22(11), 490. https://doi.org/10.3390/md22110490
Vancouver
Currie C, Bjerknes C, Framroze B. Initial Exploration of the In Vitro Activation of GLP-1 and GIP Receptors and Pancreatic Islet Cell Protection by Salmon-Derived Bioactive Peptides. Marine Drugs. 2024;22(11):490. doi:10.3390/md22110490
BibTeX
@article{Currie2024,
author = {Currie, Crawford and Bjerknes, Christian and Framroze, Bomi},
title = {Initial Exploration of the In Vitro Activation of GLP-1 and GIP Receptors and Pancreatic Islet Cell Protection by Salmon-Derived Bioactive Peptides},
journal = {Marine Drugs},
year = {2024},
volume = {22},
number = {11},
pages = {490},
doi = {10.3390/md22110490}
}
EUVIMED